Prediction of antiviral efficacy in patients with chronic hepatitis C by changes in forkhead box protein 3 levels

Experimental and Therapeutic Medicine

Volumn 8, Issue 1, 2014, Pages 165-168

  Chang, Jia Bao ^a   Xue, Rong ^a   Zhou, Zhen Xian ^a   Feng, Yan Hong ^a   Dai, Wei Wei ^a   Qiu, Jie ^a   Yang, Yong Feng ^a  

^a SOUTHEAST UNIVERSITY   (China)

Author keywords

Chronic hepatitis C; Hepatitis C virus RNA load

Indexed keywords

FORKHEAD BOX PROTEIN 3; PEPTIDES AND PROTEINS; UNCLASSIFIED DRUG;

ANTIVIRAL ACTIVITY; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CHEMILUMINESCENCE IMMUNOASSAY; CONTROLLED STUDY; DNA POLYMORPHISM; FLOW CYTOMETRY; GENE EXPRESSION; GENE MUTATION; HEPATITIS C; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MONONUCLEAR CELL; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; VIRUS LOAD;

EID: 84901346837     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2014.1675     Document Type: Article

References (18)

1. Fabrizi F, Martin P, Lunghi G and Ponticelli C: Nosocomial transmission of hepatitis C virus infection in hemodialysis patients: clinical perspectives. Int J Artif Organs 23: 805-816, 2000.
2. + regulatory T lymphocytes in hepatitis C virus infection. Hepatology 40: 1062-1071, 2004.
3. Sugimoto K, Ikeda F, Stadanlick J, Nunes FA, Alter HJ and Chang KM: Suppression of HCV-specific T cells without differential hierarchy demonstrated ex vivo in persistent HCV infection. Hepatology 38: 1437-1448, 2003.
4. + T cells during chronic hepatitis C virus infection. J Virol 79: 7860-7867, 2005.
5. Tajimi M, Ugajin T, Ota M, Hiroishi K, Nakamura I and Imawari M: Immune responses of liver-infiltrating lymphocytes and peripheral blood mononuclear cells to hepatitis C virus core and NS3 antigens. Hepatol Res 35: 250-255, 2006.
6. + regulatory T cells. Nat Immunol 4: 330-336, 2003.
7. Asseman C and von Herrath M: About CD4pos CD25pos regulatory cells. Autoimmun Rev 1: 190-197, 2002.
8. + cells in vivo. J Immunol 172: 3391-3398, 2004.
9. Sakaguchi S, Yamaguchi T, Nomura T and Ono M: Regulatory T cells and immune tolerance. Cell 133: 775-787, 2008.
10. Littman DR and Rudensky AY: Th17 and regulatory T cells in mediating and restraining inflammation. Cell 140: 845-858, 2010.
11. + T cell-mediated pulmonary hyperinflammation driven by Pneumocystis carinii in immunodeficient mice. Eur J Immunol 32: 1282-1291, 2002.
12. + regulatory T cells are essential components of the memory-protective immunity to Candida albicans. J Immunol 169: 6298-6308, 2002.
13. Mason D and Powrie F: Control of immune pathology by regulatory T cells. Curr Opin Immunol 10: 649-655, 1998.
14. Dannull J, Su Z, Rizzieri D, et al: Enhancement of vaccine-mediated antitumor immunity in cancer patients after depletion of regulatory T cells. J Clin Invest 115: 3623-3633, 2005.
15. Wan YY and Flavell RA: Regulatory T-cell functions are subverted and converted owing to attenuated Foxp3 expression. Nature 445: 766-770, 2007.
16. Williams LM and Rudensky AY: Maintenance of the Foxp3-dependent developmental program in mature regulatory T cells requires continued expression of Foxp 3. Nat Immunol 8: 277-284, 2007.
17. Ohkura N and Sakaguchi S: A novel modifier of regulatory T cells. Nat Immunol 10: 685-686, 2009.
18. + T regulatory cells suppress NK cell-mediated immunotherapy of cancer. J Immunol 176: 1582-1587, 2006.